FDA inspection
Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd.: FDA inspection ending Apr 12, 2024
FDA inspection 1231294 · No Action Indicated (NAI) · Zibo
Key facts
| Inspection ID | 1231294 |
|---|---|
| Firm | Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd. |
| FEI number | 3015541467 |
| Address | No. 1 Lutai Avenue, High-Tech District |
| City | Zibo |
| Fiscal year | 2024 |
| Inspection end date | Apr 12, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data